Categories: CancerHealthcareNews

4baseCare Secures CAP Accreditation, Elevating Genomic Profiling Standards for Cancer Patients in the UAE

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BENGALURU, India , March 17, 2025 /PRNewswire/ — 4baseCare, a leader in precision oncology, has achieved a major milestone with CAP (College of American Pathologists) accreditation for its genomics lab at Dubai Science Park, established in partnership with Innovate Life Sciences Fz-LLC. This accreditation ensures that cancer patients in the UAE now have access to world-class genomic profiling locally, meeting the highest international standards of quality and accuracy.

By securing CAP accreditation, 4baseCare reaffirms its commitment to advancing cancer care through data-driven, personalized treatment decisions. The Dubai-based facility bridges a critical gap in precision oncology, eliminating the need for patients to seek genomic testing solutions outside of the UAE .

“Our mission is to democratize access to high-quality genomic insights, empowering oncologists with cutting-edge molecular data to drive better patient outcomes,” said Dr. Sudharshan Elangovan, VP of Global Operations, 4baseCare.

Syed Hussaini, General Manager, Innovate Life Sciences, added, “This achievement underscores our dedication to quality and innovation, strengthening our mission to make precision medicine more accessible and affordable across the Middle East and beyond.”

About 4baseCare

An Illumina Accelerator company backed by Infosys Innovation Fund, 4baseCare pioneers precision oncology solutions through advanced genomics and digital health technology. 4baseCare boasts of a stellar advisory board which includes Lip Bu Tan (CEO, Intel Corporation), Francis deSouza (COO, Google Cloud and ex-CEO Illumina) and Prof George Church (Professor, Harvard Medical School).

With CAP accreditation, the company further cements its position as a trusted global partner in precision oncology, supporting healthcare providers in delivering targeted and effective cancer treatments.

Linkedin page: 4baseCare

Video: https://mma.prnewswire.com/media/2642650/4baseCare_Secures_CAP_Accreditation.mp4

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/4basecare-secures-cap-accreditation-elevating-genomic-profiling-standards-for-cancer-patients-in-the-uae-302402841.html

SOURCE 4baseCare

Staff

Recent Posts

BLUE & CO., LLC PROVIDES NOTICE OF DATA EVENT

CARMEL, Ind., July 3, 2025 /PRNewswire/ -- Blue & Co., LLC ("Blue") is a financial…

3 hours ago

Dr. Aubrey de Grey Brings Cutting-Edge Science to RAADfest 2025: LEV Foundation Partners with Coalition for Radical Life Extension

Renowned biogerontologist Dr. Aubrey de Grey to curate specialized scientific programming at world's leading longevity…

3 hours ago

NervGen Strengthens Board Leadership to Accelerate Clinical and Corporate Growth

Dr. Adam Rogers appointed chair as company advances toward key milestones following positive topline chronic…

4 hours ago

ScienceSoft Raises the Bar for AI Voice Scheduling in Healthcare

MCKINNEY, Texas--(BUSINESS WIRE)--#AI--Human-Like, Real-Time AI Scheduler launched by ScienceSoft ScienceSoft has introduced a HIPAA-compliant AI…

6 hours ago

New Podcast “Spreading the Good BUZZ” Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives

Through Hope and Community in Recovery, Sober.Buzz along with @SoberBuzzToken on Instagram are Impacting and…

9 hours ago

Services PMI® at 50.8%; June 2025 Services ISM® Report On Business®

Business Activity Index at 54.2%; New Orders Index at 51.3%; Employment Index at 47.2%; Supplier…

9 hours ago